Want to join the conversation?
$BXLT said the Japan's Ministry of Health, Labour and Welfare has approved ADYNOVATE, an extended circulating half-life recombinant Factor VIII treatment, for patients 12 years and older with hemophilia A. ADYNOVATE leverages pegylation technology reducing the speed at which it is cleared from the blood, thus resulting in increased half-life.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!